Godavari Biorefineries IPO In Talks; Files DRHP With SEBI To Raise Rs 325 Crore; Don't Miss Out On Details

Godavari Biorefineries Ltd, a player in the ethanol and bio-based chemicals sector, filed preliminary draft papers with the Securities and Exchange Board of India (SEBI) on Saturday, June 15. The company's impending initial public offering (IPO) is designed to raise substantial funds, enhancing its financial robustness and market presence.

The proposed IPO is a composite scheme involving a fresh issue of equity shares worth Rs 325 crore and an offer-for-sale (OFS) of 65.27 lakh equity shares at a face value of Rs 10 each. These shares are being offloaded by the company's promoters and an investor, as detailed in the draft red herring prospectus (DRHP). Notably, private equity firm Mandala Capital AG Ltd is divesting 49.27 lakh shares through the OFS route.

The primary purpose of the fresh issue is multifaceted. Approximately Rs 240 crore of the proceeds will be allocated towards debt repayment, a crucial step in strengthening the company's balance sheet. The remaining funds will be utilized for general corporate purposes, facilitating operational flexibility and strategic investments.

SBI Capital Markets and Equirus Capital Markets are the appointed book-running lead managers for this significant public issue, reflecting the high-profile nature of this financial manoeuvre.

Based in Maharashtra, Godavari Biorefineries Ltd stands as a titan in the Indian ethanol industry, boasting an installed capacity of 570 KLPD as of March 31, 2024. The company's clientele is a testament to its market credibility, featuring prominent names such as Hershey India Pvt Ltd, Hindustan Coca-Cola Beverages Private Limited, Karnataka Chemical Industries, and Techno Waxchem Pvt Ltd.

Godavari Biorefineries' product portfolio is impressively diverse, encompassing bio-based chemicals, sugar, various ethanol grades, and power. These products cater to a wide array of industries including food and beverages, pharmaceuticals, flavours and fragrances, power generation, fuel, personal care, and cosmetics. This diversification not only broadens the company's revenue streams but also mitigates sector-specific risks.

The company prides itself on housing India's largest integrated bio-refinery in terms of installed capacity as of March 31, 2024. Additionally, it holds the distinction of being the largest global manufacturer of MPO by installed capacity. Among its innovative milestones, Godavari Biorefineries is one of only two manufacturers of natural 1,3 butylene glycol and the sole producer of bio ethyl acetate in India. These accomplishments highlight the company's pioneering spirit and commitment to leading in bio-based chemical manufacturing.

In a notable advancement, the company also established India's first bio-based EVE manufacturing facility, setting a benchmark for industrial innovation in the country.

The bio-based chemicals market is on an exponential growth path, driven by an escalating demand for environmentally sustainable solutions. According to a Frost & Sullivan report, the market was valued at $97.2 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.4% from 2023 to 2028.

The timing of Godavari Biorefineries' IPO aligns with the increasing emphasis on sustainable industrial practices and the growing global demand for bio-based products. The funds raised through the IPO will not only aid in debt reduction but also empower the company to leverage new growth opportunities, expand its product lines, and enhance its technological capabilities.

Godavari Biorefineries Ltd's decision to go public marks a significant chapter in its corporate journey. The infusion of capital from the IPO will fortify its financial foundation, support its expansion plans, and reinforce its leadership in the bio-based chemicals sector. Investors and market observers will watch the IPO's progress, recognizing its potential impact on the company's trajectory and the broader bio-based chemicals market.